Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
AG1478
EGFR
ErbB
7864.016
uM
inf
inf
0.9663 0.9663 0.0000 0.0494
0.0019
1.4893
Hs 578T
TNBC
Basal B
AG1478
EGFR
ErbB
7863.016
uM
277.8570
950.06040
0.6475 -1.0000 0.8936 0.0611
0.8641
1.7699
Hs 578T
TNBC
Basal B
AG1478
EGFR
ErbB
7861.016
uM
53.58820
340.84020
0.1558 -1.0000 0.5938 0.1756
0.8868
2.0473
Hs 578T
TNBC
Basal B
AG1478
EGFR
ErbB
7862.016
uM
28.12640
62.54760
-0.5904 -1.0000 1.3746 0.1654
0.9947
1.3229
Hs 578T
TNBC
Basal B
AS-252424
PI3K
PI3K
10694.153
uM
inf
6.79170
0.5918 0.5917 5.0000 0.0456
0.9716
2.2940
Hs 578T
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10379.072
uM
inf
42.9060
0.6437 0.6432 4.7121 -0.0013
0.8993
2.1304
Hs 578T
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10694.072
uM
52.03210
56.00940
-0.2061 -0.2124 4.8066 0.1363
0.9654
2.1922
Hs 578T
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7471.072
uM
47.02520
55.23050
-0.5854 -0.5927 4.8610 0.1075
0.9980
2.2270
Hs 578T
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7472.072
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.2269
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7472.074
uM
0.10869
0.13354
-0.6783 -0.6933 4.2243 0.9765
0.990
1.5922
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7472.074
uM
0.10869
0.13354
-0.6783 -0.6933 4.2243 0.9765
0.990
1.5922
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
15310.203
uM
0.00955
0.01538
-0.6099 -0.6332 1.7176 1.0855
0.9927
2.4683
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
15310.203
uM
0.00955
0.01538
-0.6099 -0.6332 1.7176 1.0855
0.9927
2.4683
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7473.074
uM
0.15419
0.18046
-0.6339 -0.5980 5.0000 0.8594
0.9948
2.5364
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7473.074
uM
0.15419
0.18046
-0.6339 -0.5980 5.0000 0.8594
0.9948
2.5364
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7475.074
uM
0.09190
0.11119
-0.8733 -0.7961 4.9999 0.9925
0.9970
2.4793
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7475.074
uM
0.09190
0.11119
-0.8733 -0.7961 4.9999 0.9925
0.9970
2.4793
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7474.074
uM
0.08045
0.09811
-0.7172 -0.7007 4.4139 0.9511
0.9971
2.6218
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7474.074
uM
0.08045
0.09811
-0.7172 -0.7007 4.4139 0.9511
0.9971
2.6218
Hs 578T
TNBC
Basal B
Bosutinib
Src
nRTK
10694.145
uM
1.84520
4.1620
-0.8541 -0.8943 1.2607 0.4870
0.9970
2.2732
Hs 578T
TNBC
Basal B
Bromopyruvic acid
Hexokinase II
Metabolism
12622.177
uM
0.23724
0.28366
-0.7666 -0.7219 5.0000 0.6272
0.9991
2.5433
Hs 578T
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7864.011
uM
69.26270
94.45560
-0.9059 -0.9143 3.3516 0.4668
0.9647
1.4831
Hs 578T
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7862.011
uM
70.85350
97.69110
-0.9439 -0.9494 3.3136 0.4682
0.9738
1.3695
Hs 578T
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7863.011
uM
70.86910
95.26480
-0.7849 -0.7891 3.2014 0.3770
0.9948
2.0237
Hs 578T
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
9511.021
uM
76.14350
113.82930
-0.8699 -0.8750 2.5160 0.3515
0.9976
1.3466